Do you want to read an article? Please log in or register.
Quality of life among ischemic stroke patients eligible for endovascular treatment: analysis of the DEFUSE 3 trial
Stroke
Related content
RECOMMENDED
Stroke
Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial
JAMA Neurol.
Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW
doi: 10.1001/jamaneurol.
Stroke
Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial
Stroke
Polding LC, Tate WJ, Mlynash M, Marks MP, Heit JJ, Christensen S, Kemp S, Albers GW, Lansberg MG, DEFUSE 3 Investigators.
doi: 10.1161/STROKEAHA.120.031490
Stroke
Health-Related Quality of Life Among Patients With Acute Ischemic Stroke and Large Vessel Occlusion in the ESCAPE Trial
Stroke
Joundi RA, Rebchuk AD, Field TS, Smith EE, Goyal M, Demchuk AM, Dowlatshahi D, Poppe AY, Williams DJ, Mandzia JL, Buck BH, Jadhav AP, Pikula A, Menon BK, Hill MD, ESCAPE Trial Investigators.
doi: 10.1161/STROKEAHA.120.033872
RECOMMENDED
Stroke
Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
J Neurointerv Surg.
Nannoni S, Strambo D, Sirimarco G, Amiguet M, Vanacker P, Eskandari A, Saliou G, Wintermark M, Dunet V, Michel P
doi: 10.1136/neurintsurg-2019-015382.
Stroke
Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke
N Engl J Med.
van den Berg LA, Dijkgraaf MG, Berkhemer OA, Fransen PS, Beumer D, Lingsma HF, Majoie CB, Dippel DW, van der Lugt A, van Oostenbrugge RJ, van Zwam WH, Roos YB; MR CLEAN Investigators
doi: 10.1056/NEJMoa1612136.
Stroke
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
Lancet Neurol.
Román LS, Menon BK, Blasco J, Hernández-Pérez M, Dávalos A, Majoie CBLM, Campbell BCV, Guillemin F, Lingsma H, Anxionnat R, Epstein J, Saver JL, Marquering H, Wong JH, Lopes D, Reimann G, Desal H, Dippel DWJ, Coutts S, du Mesnil de Rochemont R, Yavagal D, Ferre JC, Roos YBWEM, Liebeskind DS, Lenthall R, Molina C, Al Ajlan FS, Reddy V, Dowlatshahi D, Nader-Antoine S, Oppenheim C, Mitha AP, Davis SM, Weimar C, van Oostenbrugge RJ, Cobo E, Kleinig TJ, Donnan GA, van der Lugt A, Demchuk AM, Berkhemer OA, Boers AMM, Ford GA, Muir KW, Brown BS, Jovin T, van Zwam WH, Mitchell PJ, Hill MD, White P, Bracard S, Goyal M; HERMES collaborators
doi: 10.1016/S1474-4422
RECOMMENDED
Stroke
Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice
JAMA.
Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE
doi: 10.1001/jama.2019.8286.
Stroke
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
JAMA.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL, Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators.
doi: 10.1001/jama.2019.9346.
Further Publications Neurology
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
JAMA Oncol.
Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R
doi: 10.1001/